您要查找的是不是：
- Suggest metabolites for the proton pump inhibitor Omeprazole. 指出质子泵抑制剂奥美拉唑的代谢物。
- Esomeprazole,a new proton pump inhibitor,is the S-i somer of omeprazole. 艾司奥美拉唑是一种新型的质子泵抑制剂，它是奥美拉唑的S-型光学异构体。
- Proton pump inhibitor (PPI) Losec seems to be the best medication for the elderly upper gastrointestinal bleeding. 质子泵抑制剂洛赛克治疗老年上消化道出血疗效显著。
- For patients with ulcer bleeding and low-risk endoscopic stigmata, high-dose oral proton pump inhibitor therapy is suggested. 对溃疡出血和低危内窥镜显小孔的患者，建议应口服大剂量质子泵抑制剂。
- Objective To evaluate the therapeutic effectiveness of the proton pump inhibitor (losec) to prevent gastroenteric reaction induced by chemotherapy. 摘要目的观察质子泵抑制剂（洛赛克）在化疗过程中对胃肠道反应的预防保护作用。
- Conclusion The proton pump inhibitor combined routine antinauseants can prevent gastroenteric reaction induced by chemotherapy and improve the QOL of patients. 结论质子泵抑制剂联合止吐剂临床应用，可以预防化疗所致的胃肠道反应并能改善化疗病人的生活质量。
- Objective To investigate the effect of proton pump inhibitor(PPI)combined H2 receptor antagonist(H2RA)in the treament of portal hypertensive gastropathy(PHG). 目的探讨质子泵抑制剂(PPI)联合H2受体拮抗剂(H2RA)在治疗门脉高压性胃病(PHG)中的作用。
- Abstract Objective:AIM To investigate the effects of proton pump inhibitor(PPI)Omeprazole on tachycardia-induced acute atrial electrical remodeling in rabbits. 目的：探讨质子泵抑制剂奥美拉唑对心房快速起搏所致家兔心房电重构的影响。
- Esomeprazole,a new proton pump inhibitor,is the S isomer of omeprazole.Its pharmacodynamic and pharmacokinetic profile,clinical trials and adverse reactions were reviewed in this paper. 艾司奥美拉唑是一种新型的质子泵抑制剂,它是奥美拉唑的S型光学异构体。本文介绍它的药效学、药代动力学、临床试验和不良反应。
- Endoscopic hemoclipping was applied and proton pump inhibitor was prescribed.The gastrocolic fistula healed ten days later.The patient remained well 24 months following initial diagnosis. 因此，实施内视镜止血夹治疗及氢离子帮浦阻断剂药物治疗，此胃大肠瘘管于十日后愈合，之后已追踪24个月仍是相当良好。
- Esomeprazole,a new proton pump inhibitor,is the S-i somer of omeprazole.Its pharmacodynamic and pharmacokinetic profile,cl inical tri als and adverse reactions were reviewed in this paper. 艾司奥美拉唑是一种新型的质子泵抑制剂，它是奥美拉唑的S-型光学异构体。本文介绍它的药效学、药代动力学、临床试验和不良反应。
- Nexium is part of a class of drugs known as proton pump inhibitors (PPIs). 耐信是质子泵抑制剂（PPI）奥美拉唑的一种异构体。
- Esomeprazole is a new member of proton pump inhibitors(PPI) with strong suppressive effects on gastric acid secretion. 埃索美拉唑是新一代质子泵抑制剂成员,有较强的抑制胃酸分泌效应。
- Proton pump inhibitors were metabolized with the sub-enzyme CYP2C19 of microsomes P450. 质子泵抑制剂奥美拉唑、兰索拉唑和盘托拉唑主要经细胞色素P450(CYP)的异构酶CYP2C19代谢消除。
- Three proton pump inhibitors have been launched: omeprazole, lansoprazole and pantoprazole in 1988,1991 and 1994, respectively. 已经上市的质子泵抑制剂有奥美拉唑(1988年上市)、兰索拉唑(1991年上市)、泮妥拉唑(1994年上市)。
- Results: Proton pump inhibitors took up the highest proportion of use frequency and money spent on antiulcer drugs in hospitalised patients. 结果：质子泵抑制剂的用药频数和用药金额在住院患者抗消化性溃疡药物应用中居首位。
- This is possible because stomach acid is needed to help the body absorb calcium - proton pump inhibitors work by slowing the production of stomach acid. 这项研究结果是可能的因为机体需要胃酸帮助吸收钙而质子泵抑制剂通过减少胃酸的产生发挥作用。
- Medical management with proton pump inhibitors is not a substitute for appropriate endoscopic therapy for patients with UGI bleeding and high-risk ulcer stigmata. 对高位胃溃疡出血和高危溃疡显小孔的患者除质子泵抑制剂治疗外，不能代替掉适当的内窥镜治疗。
- But the drugs raise the risk of stomach bleeding, so they also prescribe Nexium, made by AstraZeneca, or a rival drug in a group known as proton pump inhibitors. 但这些药物提高了胃出血的危险，因此医生也会开阿斯利康制药公司制作的艾美拉唑，或对手的药物作为质子泵抑制剂。
- The results of several studies and meta-analyses favour high-dose, intravenous proton pump inhibitors, such as omeprazole or pantoprazole, after successful endoscopic haemostasis. 根据几种研究结果和分析结果证明，静注大剂量质子原抑制剂，例如拌托啦唑、奥米啦唑、在成功的内镜止血后进行治疗很有效。
